Table 2.
Group | mFc-ACE2 inhibition (%) |
mFc-ACE2 inhibition titer (ID50) |
Neutralization Titer (D614G strain) |
Neutralization Titer (Delta strain) |
---|---|---|---|---|
|
83 | 1607 | 640 | 160 |
|
63 | 122 | ND | ND |
|
87 | 2376 | 320 | 160 |
|
86 | 5535 | 1280 | 160 |
|
86 | 3330 | 320 | 112 |
|
0 | 0 | ND | ND |
Serum pools collected fifteen days after the third dose (day 49 of the study) were evaluated in an inhibition ELISA using murine Fc ACE2 (mFc-ACE2) and RBD human Fc molecules. The neutralization titers were determined against SARS-CoV-2, using the VERO E6 cell line. ID50 is the serum dilution where 50% of binding inhibition is attained. ND: non-determined. SC: subcutaneous; IN: intranasal; MIX: simple mixture.